Long-term Outcomes of Secondary Narcolepsy in Childhood and Adolescence
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 17-005734
Sponsor Protocol Number: 17-005734
About this study
The purpose of this study is to document the long-term outcomes of secondary (symptomatic) narcolepsy in the pediatric patient population at the Mayo Clinic using chart review and mailed questionnaire.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Mayo Clinic patients with secondary narcolepsy who were between age 5 and 18 years at the time of narcolepsy diagnosis.
- The diagnosis will need to have been established on the basis of nocturnal polysomnogram (PSG) and MSLT.
- Idiopathic narcolepsy
- Hypersomnia unrelated to narcolepsy
- Age over 18 at time of diagnosis
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Suresh Kotagal, M.D.
Closed for enrollment
Publications are currently not available
Study Results Summary
Not yet available
Supplemental Study Information
Not yet available